arrow
B

Bertrand Cariou

Institut national de la santé et de la recherche médicale
H指数:77
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diurnal regulation of Acyl-CoA synthetase 3 (ACSF3) governs rhythmic mitochondrial lysine-malonylation and daily hepatic metabolism

酰基辅酶A合成酶3(ACSF3)的昼夜调控支配着节律性的线粒体赖氨酸-丙二酰化和肝脏日代谢

2026-08-010
OAAI
Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease-the ACTIDIANE randomized controlled trial

高强度身体活动与常规咨询对高风险肾脏疾病2型糖尿病患者肾功能下降的影响——ACTIDIANE随机对照试验

2026-07-010
OAAI
CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study

基于CGM的指标与接受胰岛素治疗的生活方式为2型糖尿病的老年人群的死亡率:HYPOAGE研究的二次分析

2026-06-010
OAAI
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial

Semaglutide对高危肝纤维化患者的肝纤维化和心脏结局的影响: 一项选择性随机试验的预设分析

2026-04-020
OAAI
Extracellular vesicles carrying surface-anchored adiponectin prevent obesity-related metabolic complications by enhancing insulin sensitivity

携带表面锚定脂联素的细胞外囊泡通过增强胰岛素敏感性预防肥胖相关代谢并发症

2026-04-010
OAAI
Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Society of Atherosclerosis (NSFA) and the French Society of Cardiology (SFC)

成人血脂异常的管理。法国内分泌学会(SFE)、法语区糖尿病学会(SFD)、新法语区动脉粥样硬化学会(NSFA)和法国心脏病学会(SFC)的共识声明

2025-11-190
PRE
Management of patients with type 2 diabetes and MASLD: an overview and joint statement

2型糖尿病和MASLD患者的管理:概述与联合声明

2025-10-150
PRE
French expert consensus statement on diagnosis and MANAGEMENT of PRIMARY HYPERPARATHYROIDISM

法国专家共识声明:原发性甲状旁腺功能亢进的诊断与管理

2025-08-300
PRE
Polymorphic Size of Lipoprotein(a) and Structural Bioprosthetic Valve Degeneration

脂蛋白(a)多态性大小与结构性生物假体瓣膜退化

2025-06-110
PRE
A rare gain of function variant of hepatic lipase attenuates hypercholesterolaemia and atherosclerosis in mice via an LDL receptor-independent mechanism

Sotin T, Ge X, Schönke M, Vince L, Thouzeau A, Frey S, 等. 一种肝脂肪酶罕见的获得功能变异体通过非LDL受体依赖机制减轻小鼠的高胆固醇血症和动脉粥样硬化。心血管研究. (2025) 121:1024–35. doi: 10.1093/cvr/cvaf097.

2025-06-012
OA